Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

acrivastine MeSH Supplementary Concept Data 2025


MeSH Supplementary
acrivastine
Unique ID
C043648
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C043648
Entry Term(s)
BW 825C
BW-825C
BW825C
Semprex
Pharm Action
Histamine H1 Antagonists, Non-Sedating
Registry Numbers
A20F9XAI7W
Related Numbers
87848-99-5
CAS Type 1 Name
2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-
Heading Mapped to
Triprolidine / analogs & derivatives
Frequency
71
Note
a second generation antihistamine
Source
Dermatologica 1984;169(4):179
Date of Entry
1985/01/03
Revision Date
2016/12/21
acrivastine Preferred
BW 825C Narrower
Semprex Narrower
page delivered in 0.005s